000 02371nam a22005175i 4500
001 u378288
003 SIRSI
005 20160812084546.0
007 cr nn 008mamaa
008 110815s2011 ne | s |||| 0|eng d
020 _a9789400703445
_9978-94-007-0344-5
040 _cMX-MeUAM
050 4 _aRC261-271
082 0 4 _a614.5999
_223
100 1 _aHayat, M. A.
_eeditor.
245 1 0 _aTumors of the Central Nervous System, Volume 1
_h[recurso electrónico] :
_bGliomas: Glioblastoma (Part 1) /
_cedited by M. A. Hayat.
264 1 _aDordrecht :
_bSpringer Netherlands,
_c2011.
300 _aXXII, 434 p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aTumors of the Central Nervous System ;
_v1
520 _aThe most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed.
650 0 _aMedicine.
650 0 _aOncology.
650 0 _aRadiology, Medical.
650 0 _aNeurosurgery.
650 0 _aPathology.
650 0 _aSurgery.
650 1 4 _aBiomedicine.
650 2 4 _aCancer Research.
650 2 4 _aNeuroradiology.
650 2 4 _aNeurosurgery.
650 2 4 _aOncology.
650 2 4 _aPathology.
650 2 4 _aSurgery.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789400703438
830 0 _aTumors of the Central Nervous System ;
_v1
856 4 0 _zLibro electrónico
_uhttp://148.231.10.114:2048/login?url=http://link.springer.com/book/10.1007/978-94-007-0344-5
596 _a19
942 _cLIBRO_ELEC
999 _c206168
_d206168